International Journal of Radiation Oncology * Biology * Physics
Volume 49, Issue 2 , Pages 353-365, 1 February 2001

Normal tissue radiobiology: from the laboratory to the clinic

Presented at ICTR 2000, Lugano, Switzerland, March 5–8, 2000.

  • R.P Hill, Ph.D.

      Affiliations

    • Ontario Cancer Institute, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests to: Dr. R. P. Hill, Research Division, Ontario Cancer Institute/Princess Margaret Hospital, 610, University Avenue, Toronto, Ontario, Canada M5G 2M9
  • ,
  • H.-P Rodemann, Ph.D.

      Affiliations

    • Department of Radio-Oncology, Eberhard-Karls-University Tubingen, Tubingen, Germany
  • ,
  • J.H Hendry, Ph.D. (D.Sc.)

      Affiliations

    • Paterson Institute for Cancer Research, Christie Hospital, Manchester, UK
  • ,
  • S.A Roberts, Ph.D.

      Affiliations

    • Paterson Institute for Cancer Research, Christie Hospital, Manchester, UK
  • ,
  • M.S Anscher, M.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical School, Durham, NC, USA

Accepted 31 August 2000.

Abstract 

This manuscript is in four parts, presenting the four talks given in a symposium on normal tissue radiobiology. The first part addresses the general concept of the role of parenchymal cell radiosensitivity vs. other factors, highlighting research over the last decade that has altered our understanding of factors underlying normal tissue response. The other three parts expand on specific themes raised in the first part dealing in particular with (1) modifications of fibroblast response to irradiation in relation to the induction of tissue fibrosis, (2) the use of the linear–quadratic equation to model the potential benefits of using different means (both physical and biologic) of modifying normal tissue response, and (3) the specific role of the growth factor TFG-β1 in normal tissue response to irradiation. The symposium highlights the complexities of the radiobiology of late normal tissue responses, yet provides evidence and ideas about how the clinical problem of such responses may be modified or alleviated.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0360-3016(00)01484-X

International Journal of Radiation Oncology * Biology * Physics
Volume 49, Issue 2 , Pages 353-365, 1 February 2001